Lipidomic analyses further showed that several glycerophospholipid species, including phosphatidylcholines, were impacted by the midlife apoE ε4:apoE ε2 allele switch, which is consistent with previous post mortem human AD studies. The gene discussed is APOE; the disease is Alzheimer disease.